نتایج جستجو برای: antifungal resistance

تعداد نتایج: 396617  

Journal: :The Journal of antimicrobial chemotherapy 2014
H Ruth Ashbee Rosemary A Barnes Elizabeth M Johnson Malcolm D Richardson Rebecca Gorton William W Hope

The burden of human disease related to medically important fungal pathogens is substantial. An improved understanding of antifungal pharmacology and antifungal pharmacokinetics-pharmacodynamics has resulted in therapeutic drug monitoring (TDM) becoming a valuable adjunct to the routine administration of some antifungal agents. TDM may increase the probability of a successful outcome, prevent dr...

Journal: :Clinical microbiology reviews 2009
Richard D Cannon Erwin Lamping Ann R Holmes Kyoko Niimi Philippe V Baret Mikhail V Keniya Koichi Tanabe Masakazu Niimi Andre Goffeau Brian C Monk

Fungi cause serious infections in the immunocompromised and debilitated, and the incidence of invasive mycoses has increased significantly over the last 3 decades. Slow diagnosis and the relatively few classes of antifungal drugs result in high attributable mortality for systemic fungal infections. Azole antifungals are commonly used for fungal infections, but azole resistance can be a problem ...

Journal: :The Yale Journal of Biology and Medicine 1999
E. Dun

The increased number of vaginal yeast infections in the past few years has been a disturbing trend, and the scientific community has been searching for its etiology. Several theories have been put forth to explain the apparent increase. First, the recent widespread availability of low-dosage, azole-based over-the-counter antifungal medications for vaginal yeast infections encourages women to se...

2017
Juliana Alves Parente-Rocha Alexandre Melo Bailão André Correa Amaral Carlos Pelleschi Taborda Juliano Domiraci Paccez Clayton Luiz Borges Maristela Pereira

Diseases caused by fungi can occur in healthy people, but immunocompromised patients are the major risk group for invasive fungal infections. Cases of fungal resistance and the difficulty of treatment make fungal infections a public health problem. This review explores mechanisms used by fungi to promote fungal resistance, such as the mutation or overexpression of drug targets, efflux and degra...

2014
Dimitrios Farmakiotis Jeffrey J. Tarrand Dimitrios P. Kontoyiannis

Cancer patients are at risk for candidemia, and increasing Candida spp. resistance poses an emerging threat. We determined rates of antifungal drug resistance, identified factors associated with resistance, and investigated the correlation between resistance and all-cause mortality rates among cancer patients with ≥1 C. glabrata-positive blood culture at MD Anderson Cancer Center, Houston, Texa...

2004
Mary Ann Jabra-Rizk William A. Falkler Timothy F. Meiller

Candida species, including the novel opportunistic pathogen Candida dubliniensis, are now emerging as major agents of nosocomial infections. Many such manifestations of infections associated with the formation of Candida biofilms include those occurring on devices such as indwelling intravascular catheters. Fungal biofilm-associated infections are frequently refractory to conventional therapy b...

2017
Anisa LITI

The epidemiology of Candida infections has changed in recent years. Although Candida albicans is still the main cause of invasive candidiasis in most clinical settings. The use of antifungal drugs in the therapy of fungal diseases can lead to the development of antifungal resistance. A better understanding of the mechanisms and clinical impact of antifungal drug resistance is essential for the ...

2016
Tanvi Shekhar-Guturja G M Kamal B Gunaherath E M Kithsiri Wijeratne Jean-Philippe Lambert Anna F Averette Soo Chan Lee Taeyup Kim Yong-Sun Bahn Farida Tripodi Ron Ammar Katja Döhl Karolina Niewola-Staszkowska Lutz Schmitt Robbie J Loewith Frederick P Roth Dominique Sanglard David Andes Corey Nislow Paola Coccetti Anne-Claude Gingras Joseph Heitman A A Leslie Gunatilaka Leah E Cowen

There is an urgent need for new strategies to treat invasive fungal infections, which are a leading cause of human mortality. Here, we establish two activities of the natural product beauvericin, which potentiates the activity of the most widely deployed class of antifungal against the leading human fungal pathogens, blocks the emergence of drug resistance, and renders antifungal-resistant path...

2015
Sri Janani Anupma J. Kindo

Candida sp is the fourth most common cause of bloodstream infections all over the world, which is invasive and life-threatening. Invasive infections caused by Candida leads to increased mortality and morbidity in immunocompromised patients, in spite of recent advances in preventive, diagnostic, and therapeutic procedures. The antifungal resistance pattern in such high-risk patients is a major c...

ژورنال: طلوع بهداشت یزد 2018

 Introduction: By development of bacterial drug-resistance to traditional antibacterial drugs and fungal  infections, the need to design, synthesis, and use of new and effective antibacterial and antifungal drugs is increased. Quinazolinone derivatives are heterocyclic compounds with nitrogen atoms that have pharmacological properties such as anti-bacterial, anti-tumor, anti-inflammatory and an...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید